Note AcademyNote Academy

Biology · Oct / Nov 2024 · Paper 11 · Question 5

YBI11

As printed in the paper

The question as text

5 Warfarin is used as an anticoagulant to treat some patients. Patients respond differently to this drug. This makes it difficult for doctors to select a safe but effective dose of warfarin to give to each patient. Factors that affect the response of a patient to warfarin include age, body mass, liver function and genetic makeup.

Read automatically from the paper; the printed page above is exact.

Show the answer and mark scheme
  • 5(a)[2]

    A description that includes the following points:

    to carry a copy of the gene {out of the nucleus / into the

    ACCEPT {(genetic) code / DNA base

    cytoplasm / to the ribosomes} (1)

    sequence / DNA} if reference to the

    enzyme has been made

    NB copy is the noun not the verb

    (used for) {(correct) ordering of the amino acids / producing

    amino acid sequence / formation of (poly)peptide chain} (1)

    Advantages of pharmacogenomics:

    genotype {affects / determines} the dose of warfarin needed
    so one dose will not be appropriate for all patients
    as the two genes that have several alleles
    (one / two) gene M allele that slows down breakdown means less warfarin accept converse for other alleles
    one gene V allele results in less enzyme V / mRNA so less warfarin should be prescribed – accept converse for other alleles
    other genetic predispositions maybe identified e.g. high cholesterol, high blood pressure

    Effect of other factors:

    factors other than genotype affects blood clotting so these would need to be taken into account as well
    e.g. people with high cholesterol more likely to be prescribed warfarin
    mass of warfarin would need to be adjusted according to body size / given at a particular dose in mgs per kg
    liver function may affect the half life of the drug

    Issues surrounding genetic screening:

    there are religious / moral / social / ethical issues relating to genetic screening

    people / family may not want to find out if there are any other underlying genetic issues

    possibility of false negative / positive results

    Blood clotting:

    thromboplastin converts prothrombin into thrombin which converts fibrinogen into fibrin to trap platelets

    Level 0

    0

    No awardable content

    Level 1

    12

    Demonstrates isolated elements of biological knowledge and

    Simple points made

    understanding to the given context with generalised comments made.

    Vague statements related to consequences are made with limited linkage

    1 mark = 1 point made

    to a range of scientific ideas, processes, techniques and procedures. The

    2 marks = some attempt to comment on pharmacogenetics

    discussion will contain basic information with some attempt made to link

    or factors that affect it

    knowledge and understanding to the given context.

    OR

    description of blood clotting process

    Level 2

    34

    Demonstrates adequate knowledge and understanding by selecting and

    Simple discussion of pharmacogenetics

    applying some relevant biological facts / concepts. Consequences are

    discussed which are occasionally supported through linkage to a range of

    3 marks = implications of genotype for either gene M or

    scientific ideas, processes, techniques and procedures. The discussion

    gene V on warfarin dose

    shows some linkages and lines of scientific reasoning with some

    4 marks = implications of genotype for both gene M and

    structure.

    gene V on warfarin dose

    Level 3

    56

    Demonstrates comprehensive knowledge and understanding by selecting

    Understanding of other issues involved

    and applying relevant biological facts / concepts. Consequences are

    discussed which supported throughout by sustained linkage to a range of

    5 marks = criteria for 4 marks plus links made with either

    scientific ideas, processes, techniques and procedures. The discussion

    blood clotting process or other factors or issues of

    shows a welldeveloped and sustained line of scientific reasoning which is

    screening

    clear and logically structured.

    6 marks = criteria for 4 marks plus links made with two

    from blood clotting process / other factors / issues

    surrounding screening

  • 5(b)(i)[8]

    A description that includes the following points:

    to carry a copy of the gene {out of the nucleus / into the

    ACCEPT {(genetic) code / DNA base

    cytoplasm / to the ribosomes} (1)

    sequence / DNA} if reference to the

    enzyme has been made

    NB copy is the noun not the verb

    (used for) {(correct) ordering of the amino acids / producing

    amino acid sequence / formation of (poly)peptide chain} (1)

    Advantages of pharmacogenomics:

    genotype {affects / determines} the dose of warfarin needed
    so one dose will not be appropriate for all patients
    as the two genes that have several alleles
    (one / two) gene M allele that slows down breakdown means less warfarin accept converse for other alleles
    one gene V allele results in less enzyme V / mRNA so less warfarin should be prescribed – accept converse for other alleles
    other genetic predispositions maybe identified e.g. high cholesterol, high blood pressure

    Effect of other factors:

    factors other than genotype affects blood clotting so these would need to be taken into account as well
    e.g. people with high cholesterol more likely to be prescribed warfarin
    mass of warfarin would need to be adjusted according to body size / given at a particular dose in mgs per kg
    liver function may affect the half life of the drug

    Issues surrounding genetic screening:

    there are religious / moral / social / ethical issues relating to genetic screening

    people / family may not want to find out if there are any other underlying genetic issues

    possibility of false negative / positive results

    Blood clotting:

    thromboplastin converts prothrombin into thrombin which converts fibrinogen into fibrin to trap platelets

    Level 0

    0

    No awardable content

    Level 1

    12

    Demonstrates isolated elements of biological knowledge and

    Simple points made

    understanding to the given context with generalised comments made.

    Vague statements related to consequences are made with limited linkage

    1 mark = 1 point made

    to a range of scientific ideas, processes, techniques and procedures. The

    2 marks = some attempt to comment on pharmacogenetics

    discussion will contain basic information with some attempt made to link

    or factors that affect it

    knowledge and understanding to the given context.

    OR

    description of blood clotting process

    Level 2

    34

    Demonstrates adequate knowledge and understanding by selecting and

    Simple discussion of pharmacogenetics

    applying some relevant biological facts / concepts. Consequences are

    discussed which are occasionally supported through linkage to a range of

    3 marks = implications of genotype for either gene M or

    scientific ideas, processes, techniques and procedures. The discussion

    gene V on warfarin dose

    shows some linkages and lines of scientific reasoning with some

    4 marks = implications of genotype for both gene M and

    structure.

    gene V on warfarin dose

    Level 3

    56

    Demonstrates comprehensive knowledge and understanding by selecting

    Understanding of other issues involved

    and applying relevant biological facts / concepts. Consequences are

    discussed which supported throughout by sustained linkage to a range of

    5 marks = criteria for 4 marks plus links made with either

    scientific ideas, processes, techniques and procedures. The discussion

    blood clotting process or other factors or issues of

    shows a welldeveloped and sustained line of scientific reasoning which is

    screening

    clear and logically structured.

    6 marks = criteria for 4 marks plus links made with two

    from blood clotting process / other factors / issues

    surrounding screening

Make a free account to save your answers and see your weak topics and ask the AI why a wrong answer is wrong.